A Study to Evaluate the Safety of HIN1 Monovalent Vaccine (MEDI3414) in Children 2 to 17 Years of Age
Public ClinicalTrials.gov record NCT00946101. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of MEDI3414 in Children
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study was to determine the safety and descriptive immunogenicity of the H1N1 influenza vaccine in healthy children.
Study identification
- NCT ID
- NCT00946101
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 326 participants
Conditions and interventions
Conditions
Interventions
- MEDI3414 [Influenza A(H1N1) live attenuated, intranasal] Biological
- Placebo Biological
Biological
Eligibility (public fields only)
- Age range
- 2 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2009 (Type not available)
- Primary completion
- Sep 2009 (Actual)
- Completion
- Mar 2010 (Actual)
- Last update posted
- Aug 11, 2011
2009 – 2010
United States locations
- U.S. sites
- 16
- U.S. states
- 11
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Coastal Clinic Research, Inc. | Mobile | Alabama | 36608 | — |
| Benchmark Research | Sacramento | California | 95816 | — |
| California Research Foundation | San Diego | California | 92103-6204 | — |
| Benchmark Research | San Francisco | California | 94102 | — |
| Kentucky Pediatric Research Center | Bardstown | Kentucky | 40004 | — |
| Central Kentucky Research Associates, Inc. | Lexington | Kentucky | 40509 | — |
| Sundance Clinical Research | St Louis | Missouri | 63141 | — |
| Meridian Clinical Research | Omaha | Nebraska | 68134 | — |
| Clinical Research Center of Nevada | Henderson | Nevada | 89105 | — |
| Rochester Clinical Research Inc. | Rochester | New York | 14069 | — |
| Primary Physicians Research, Inc. | Pittsburgh | Pennsylvania | 15241 | — |
| Omega Medical Research | Warwick | Rhode Island | 02886 | — |
| Spartanburg Medical Research | Spartanburg | South Carolina | 29303 | — |
| Benchmark Research | Austin | Texas | 78705 | — |
| Benchmark Research Ft. Worth | Fort Worth | Texas | 76135 | — |
| Benchmark Research San Angelo | San Angelo | Texas | 76904 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00946101, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 11, 2011 · Synced Oct 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00946101 live on ClinicalTrials.gov.